参考文献/References:
[1]HippiusH,Neund?ferG.ThediscoveryofAlzheimer’sdisease[J].DialoguesinClinicalNeuroscience,2003,5(1):101-108.
[2]PattersonC.WorldAlzheimerreport2018:thestateoftheartofdementiaresearch:Newfrontiers[J].Alzheimer’sDiseaseInternational(ADI):London,UK,2018,
[3]LaneCA,HardyJ,SchottJM.Alzheimer’sdisease[J].EuropeanJournalofNneurology,2018,25(1):59-70.
[4]TheneedforearlydetectionandtreatmentinAlzheimer’sdisease[J].EBioMedicine,2016,9:1-2.
[5]Maliszewska-CynaE,LynchM,OoreJJ,etal.ThebenefitsofexerciseandmetabolicinterventionsforthepreventionandearlytreatmentofAlzheimer’sdisease[J].CurrentAlzheimerResearch,2017,14(1):47-60.
[6]GrahamWV,Bonito-OlivaA,SakmarTP.UpdateonAlzheimer’sdiseasetherapyandpreventionstrategies[J].AnnuRevMed,2017,68:413-430.
[7]DosSantosPicancoLC,OzelaPF,DeFatimaDeBritoBritoM,etal.Alzheimer’sdisease:Areviewfromthepathophysiologytodiagnosis,newperspectivesforpharmacologicaltreatment[J].CurrMedChem,2018,25(26):3141-3159.
[8]MolinuevoJL,AytonS,BatrlaR,etal.CurrentstateofAlzheimer’sfluidbiomarkers[J].Actaneuropathologica,2018,136(6):821-853.
[9]DuboisB,FeldmanHH,JacovaC,etal.AdvancingresearchdiagnosticcriteriaforAlzheimer’sdisease:theIWG-2criteria[J].LancetNeurol,2014,13(6):614-629.
[10]ScheltensP,BlennowK,BretelerMM,etal.Alzheimer’sdisease[J].Lancet(London,England),2016,388(10043):505-517.
[11]OlssonB,LautnerR,AndreassonU,etal.CSFandbloodbiomarkersforthediagnosisofAlzheimer’sdisease:asystematicreviewandmeta-analysis[J].TheLancetNeurology,2016,15(7):673-684.
[12]VlassenkoAG,MccueL,JasielecMS,etal.Imagingandcerebrospinalfluidbiomarkersinearlypreclinicalalzheimerdisease[J].AnnalsofNeurology,2016,80(3):379-387.
[13]PalmqvistS,MattssonN,HanssonO.Cerebrospinalfluidanalysisdetectscerebralamyloid-βaccumulationearlierthanpositronemissiontomography[J].Brain:AJournalofNeurology,2016,139(Pt4):1226-1236.
[14]PomaraN,WilloughbyLM,idtisJJ,etal.SelectivereductionsinplasmaAbeta1-42inhealthyelderlysubjectsduringlongitudinalfollow-up:apreliminaryreport[J].TheAmericanJournalofGeriatricPsychiatry:OfficialJournaloftheAmericanAssociationforGeriatricPsychiatry,2005,13(10):914-917.
[15]NakamuraA,KanekoN,VillemagneVL,etal.Highperformanceplasmaamyloid-βbiomarkersforAlzheimer’sdisease[J].Nature,2018,554(7691):249-254.
[16]L?heimH,ElghF,JohanssonA,etal.PlasmaconcentrationsoffreeamyloidβcannotpredictthedevelopmentofAlzheimer’sdisease[J].Alzheimer’s&Dementia:theJournaloftheAlzheimer’sAssociation,2017,13(7):778-782.
[17]ParkJC,HanSH,ChoHJ,etal.ChemicallytreatedplasmaAβisapotentialblood-basedbiomarkerforscreeningcerebralamyloiddeposition[J].Alzheimer’sRsearch&Therapy,2017,9(1):20.
[18]CountsSE,IkonomovicMD,MercadoN,etal.BiomarkersfortheearlydetectionandprogressionofAlzheimer’sdisease[J].Neurotherapeutics:theJournaloftheAmericanSocietyforExperimentalNeuroTherapeutics,2017,14(1):35-53.
[19]LleoA,CavedoE,ParnettiL,etal.CerebrospinalfluidbiomarkersintrialsforAlzheimerandParkinsondiseases[J].NaturereviewsNeurology,2015,11(1):41-55.
[20]BlennowK,HampelH,WeinerM,etal.CerebrospinalfluidandplasmabiomarkersinAlzheimerdisease[J].NatureReviewsNeurology,2010,6(3):131-144.
[21]MielkeMM,HagenCE,WennbergAMV,etal.AssociationofPlasmatotalTaulevelwithcognitivedeclineandriskofmildcognitiveimpairmentordementiainthemayoclinicstudyonaging[J].JAMANeurology,2017,74(9):1073-1080.
[22]YangCC,ChiuMJ,ChenTF,etal.AssayofplasmaphosphorylatedTauprotein(threonine181)andtotalTauproteininearly-stageAlzheimer’sdisease[J].JournalofAlzheimer’sDisease:JAD,2018,61(4):1323-1332.
[23]MattssonN,ZetterbergH,JanelidzeS,etal.PlasmatauinAlzheimerdisease[J].Neurology,2016,87(17):1827-1835.
[24]MartinSJ,McglassonS,HuntD,etal.Cerebrospinalfluidneurofilamentlightchaininmultiplesclerosisanditssubtypes:ameta-analysisofcase-controlstudies[J].JNeurolNeurosurgPsychiatry,2019,90(9):1059-1067.
[25]ZetterbergH,Skillb?kT,MattssonN,etal.AssociationofcerebrospinalfluidneurofilamentlightconcentrationwithAlzheimerdiseaseprogression[J].JAMANeurology,2016,73(1):60-67.
[26]GisslénM,PriceRW,AndreassonU,etal.Plasmaconcentrationoftheneurofilamentlightprotein(NFL)isabiomarkerofCNSinjuryinHIVinfection:Across-sectionalstudy[J].EBioMedicine,2016,3:135-140.
[27]MattssonN,AndreassonU,ZetterbergH,etal.AssociationofplasmaneurofilamentlightwithneurodegenerationinpatientswithAlzheimerdisease[J].JAMANeurology,2017,74(5):557-566.
[28]WestonPSJ,PooleT,RyanNS,etal.SerumneurofilamentlightinfamilialAlzheimerdisease:Amarkerofearlyneurodegeneration[J].Neurology,2017,89(21):2167-2175.
[29]HampelH,O’bryantSE,MolinuevoJL,etal.Blood-basedbiomarkersforAlzheimerdisease:mappingtheroadtotheclinic[J].NatureReviewsNeurology,2018,14(11):639-652.
[30]WuG,SankaranarayananS,WongJ,etal.Characterizationofplasmaβ-secretase(BACE1)activityandsolubleamyloidprecursorproteinsaspotentialbiomarkersforAlzheimer’sdisease[J].Journalofneuroscienceresearch,2012,90(12):2247-2258.
[31]ShenY,WangH,SunQ,etal.Increasedplasmabeta-secretase1maypredictconversiontoAlzheimer’sdiseasedementiainindividualswithmildcognitiveimpairment[J].Biologicalpsychiatry,2018,83(5):447-455.
[32]MonteSM,GhanbariK,FreyWH,etal.CharacterizationoftheAD7C-NTPcDNAexpressioninAlzheimer’sdiseaseandmeasurementofa41-kDproteinincerebrospinalfluid[J].TheJournalofclinicalinvestigation,1997,100(12):3093-3104.
[33]ZhangJ,ZhangCH,LiRJ,etal.AccuracyofurinaryAD7c-NTPfordiagnosingAlzheimer’sdisease:asystematicreviewandmeta-analysis[J].JournalofAlzheimer’sDisease:JAD,2014,40(1):153-159.
[34]ChenY,ShiS,ZhangJ,etal.DiagnosticvalueofAD7C-NTPforpatientswithmildcognitiveimpairmentduetoAlzheimer’sdisease[J].ZhonghuaYiXueZaZhi,2014,94(21):1613-1617.
[35]王艳,李攀,陈嫄,等.尿液AD7c-NTP表达变化对痴呆诊断价值的探讨[J].中国现代神经疾病杂志,2015,15(8):649-654.
[36]DeLaMonteSM,WandsJR.TheAD7c-NTPneuronalthreadproteinbiomarkerfordetectingAlzheimer’sdisease[J].JournalofAlzheimer’sdisease:JAD,2001,3(3):345-353.
[37]ThéryC,ZitvogelL,AmigorenaS.Exosomes:composition,biogenesisandfunction[J].NatureReviewsImmunology,2002,2(8):569-579.
[38]LaulagnierK,JavaletC,HemmingFJ,etal.Amyloidprecursorproteinproductsconcentrateinasubsetofexosomesspecificallyendocytosedbyneurons[J].CellularandMolecularLifeSciences:CMLS,2018,75(4):757-773.
[39]SamanS,KimW,RayaM,etal.Exosome-associatedtauissecretedintauopathymodelsandisselectivelyphosphorylatedincerebrospinalfluidinearlyAlzheimerdisease[J].TheJournalofBiologicalChemistry,2012,287(6):3842-3849.
[40]FiandacaMS,KapogiannisD,MapstoneM,etal.IdentificationofpreclinicalAlzheimer’sdiseasebyaprofileofpathogenicproteinsinneurallyderivedbloodexosomes:Acase-controlstudy[J].Alzheimer’s&Ddementia:theJournaloftheAlzheimer’sAssociation,2015,11(6):600-607.
[41]MillanMJ.Linkingderegulationofnon-codingRNAtothecorepathophysiologyofAlzheimer’sdisease:Anintegrativereview[J].ProgNeurobiol,2017,156:1-68.
[42]SwarbrickS,WraggN,GhoshS,etal.SystematicreviewofmiRNAasbiomarkersinAlzheimer’sdisease[J].MolNeurobiol,2019,56(9):6156-6167.
[43]ShaltielG,HananM,WolfY,etal.HippocampalmicroRNA-132mediatesstress-induciblecognitivedeficitsthroughitsacetylcholinesterasetarget[J].BrainStructure&Function,2013,218(1):59-72.
[44]YeY,XuH,SuX,etal.RoleofmicroRNAingoverningsynapticplasticity[J].NeuralPlasticity,2016,2016:495-523.
[45]XieB,ZhouH,ZhangR,etal.SerummiR-206andmiR-132aspotentialcirculatingbiomarkersformildcognitiveimpairment[J].JournalofAlzheimer’sdisease:JAD,2015,45(3):721-731.
[46]WuHZ,OngKL,SeeherK,etal.CirculatingmicroRNAsasbiomarkersofAlzheimer’sdisease:Asystematicreview[J].JournalofAlzheimer’sDsease:JAD,2016,49(3):755-766.
[47]ConsensusreportoftheWorkingGroupon:"MolecularandBiochemicalMarkersofAlzheimer’sDisease".TheronaldandnancyreaganresearchinstituteoftheAlzheimer’sassociationandtheNationalinstituteonagingworkinggroup[J].NeurobiologyofAging,19(2):109-116.